Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,350,100
+$38,262,849 QoQ
Shares Held
4,190,195
+47.2% QoQ
Ownership
2.77%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#8
of 294 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Dec 31, 2025CallValue
$509,179
CallShares
45,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. BHVN ranks #21 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in BHVN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,350,100 | 4,190,195 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,087,251 | 2,847,193 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,417,901 | 2,694,234 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $509,179 | 45,100 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $19,014,547 | 1,266,792 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,319,971 | 518,779 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $830,870 | 34,562 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,373,664 | 170,647 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,868,818 | 577,723 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,758,185 | 540,426 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,018,797 | 256,332 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,982,906 | 209,881 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $287,254 | 11,044 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $361,685 | 26,058 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||